Related Experiment Video
Updated: Aug 2, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
The path to tuberculosis elimination: a renewed vision.
Giovanni Battista Migliori1,2, David Dowdy3,2, Justin T Denholm4,5,2
1Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy giovannibattista.migliori@icsmaugeri.it.
Achieving tuberculosis (TB) pre-elimination requires accelerating efforts even in low-incidence countries. This review proposes a staged framework to guide progress toward TB elimination, focusing on actionable steps and tailored strategies.
Area of Science:
- Public Health
- Epidemiology
- Infectious Disease Control
Background:
- Tuberculosis (TB) elimination and pre-elimination goals were set in the 1990s for low-incidence countries.
- Current progress indicates a need for accelerated efforts to achieve pre-elimination even in well-resourced settings.
Purpose of the Study:
- To review the history and current status of TB elimination efforts.
- To propose a framework for accelerating progress towards TB pre-elimination.
- To guide stakeholders in actionable steps for TB control.
Main Methods:
- Review of historical TB elimination concepts and country experiences.
- Analysis of available interventions for TB control.
- Development of a five-stage framework for TB incidence reduction.
Main Results:
- A five-stage framework (high, moderate, low incidence, nearing pre-elimination, pre-elimination) is proposed, benchmarked by TB incidence levels.
- Countries can set 5-year targets for TB incidence reduction or stage progression.
- Prioritization of activities, tailored strategies, and consideration of ethical concerns are crucial.
Conclusions:
- The proposed framework provides actionable steps for countries to accelerate progress towards TB pre-elimination.
- Tailored strategies and accountability are key to achieving TB elimination goals.
- Addressing ethical and social concerns is important as pre-elimination is approached.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

